United States · Biotechnology startup

Cerevel Therapeutics

Cerevel Therapeutics is a biopharmaceutical company that develops drugs to treat neurological and neuropsychiatric disorders.

Funding reportedLast round: Post ipo equity

BiotechnologyBoston, United States

What company datasets say Cerevel Therapeutics raised

Funding, as reported

Reported in all$1.9Bin dollars
Rounds6
Last roundPost ipo equity
Last round dateOct 2023
Investors listed19

On 3 portfolio pages

Investors who name them

Each firm lists Cerevel Therapeutics on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

Biotechnology in United States

Startups like it

Is this your company?

Add your raise, your deck and your story, and put Cerevel Therapeutics in front of investors. Or tell us what we have wrong.

List your startupSend a correction